Publication

Article

June 22, 2009

CURE

Spring 2006

Volume5

Issue 1

Recommended Resources

Resources recommended for when dealing with Medicare.

>

www.aarp.org

AARP 888-687-2277

> Centers for Medicare & Medicaid Services 800-633-4227 my.medicare.gov www.medicare.gov > Patient Advocate Foundation 800-532-5274 www.patientadvocate.org > Social Security Administration 800-772-1213 www.ssa.gov/prescriptionhelp > State Health Insurance Assistance Programs www.shiptalk.org

Articles in this issue

Quick Relief for Breakthrough Pain

Easing Bone Pain

Co-Survivor Essays

Supporting Co-Survivors

Recommended Resources

How Part D Came to Be

Novel Cytokines for RCC

An Unpleasant Surprise

Taking a Closer Look

Staging Kidney Cancer

Web Exclusive: Q&A with Dr. Dennis Slamon

Web Exclusive: A Dangerous Side Effect

In the Beginning

Pathway to Herceptin Success

Closer to Relief

Newsletter

Stay up to date on cancer updates, research and education

Related Content

Image of hand.

June 10th 2025

Oncology Nurse Amanda Snyder Turns Personal Experience Into Advocacy

Amanda Snyder, a cancer survivor, became an oncology nurse to provide support she once lacked, now leading innovative therapies for patients.

How artificial intelligence is being used to augment the work of experts treating patients with prostate cancer.

June 7th 2025

Utilizing AI in Prostate Cancer Care and Management

How artificial intelligence is being used to augment the work of experts treating patients with prostate cancer.

CURE spoke with the principal investigator of a clinical trial evaluating a therapeutic vaccine in advanced kidney cancer: © stock.adobe.com.

June 6th 2025

Personalized Vaccine Elicits Responses in Patients With Kidney Cancer

CURE spoke with the principal investigator of a clinical trial evaluating a therapeutic vaccine for patients with advanced kidney cancer.

New treatment combinations are transforming genitourinary cancer care: © stock.adobe.com.

May 30th 2025

Rapid Developments to Enhance Patient Experience in GU Cancer

Dr. John L. Gore

New treatment combinations are transforming genitourinary cancer care, improving survival and quality of life while personalizing patient outcomes.

Antihistamines may be associated with survival improvement in patients with metastatic urothelial carcinoma receiving Tecentriq: © stock.adobe.com

May 30th 2025

Additive Antihistamines May Improve Metastatic Bladder Cancer Outcomes

Antihistamines may be associated with survival improvement in patients with metastatic urothelial carcinoma receiving Tecentriq.

A powerful new ally is emerging in cancer care: artificial intelligence: © stock.adobe.com.

May 27th 2025

The Dawn of AI in Prostate Cancer Care

Mike Hennessy Jr.

A powerful new ally is emerging in cancer care: artificial intelligence.

Related Content

Image of hand.

June 10th 2025

Oncology Nurse Amanda Snyder Turns Personal Experience Into Advocacy

Amanda Snyder, a cancer survivor, became an oncology nurse to provide support she once lacked, now leading innovative therapies for patients.

How artificial intelligence is being used to augment the work of experts treating patients with prostate cancer.

June 7th 2025

Utilizing AI in Prostate Cancer Care and Management

How artificial intelligence is being used to augment the work of experts treating patients with prostate cancer.

CURE spoke with the principal investigator of a clinical trial evaluating a therapeutic vaccine in advanced kidney cancer: © stock.adobe.com.

June 6th 2025

Personalized Vaccine Elicits Responses in Patients With Kidney Cancer

CURE spoke with the principal investigator of a clinical trial evaluating a therapeutic vaccine for patients with advanced kidney cancer.

New treatment combinations are transforming genitourinary cancer care: © stock.adobe.com.

May 30th 2025

Rapid Developments to Enhance Patient Experience in GU Cancer

Dr. John L. Gore

New treatment combinations are transforming genitourinary cancer care, improving survival and quality of life while personalizing patient outcomes.

Antihistamines may be associated with survival improvement in patients with metastatic urothelial carcinoma receiving Tecentriq: © stock.adobe.com

May 30th 2025

Additive Antihistamines May Improve Metastatic Bladder Cancer Outcomes

Antihistamines may be associated with survival improvement in patients with metastatic urothelial carcinoma receiving Tecentriq.

A powerful new ally is emerging in cancer care: artificial intelligence: © stock.adobe.com.

May 27th 2025

The Dawn of AI in Prostate Cancer Care

Mike Hennessy Jr.

A powerful new ally is emerging in cancer care: artificial intelligence.

Advertise / Support

Editorial Board

CancerNetwork.com

TargetedOnc.com

OncNursingNews.com

Terms & Conditions

Do Not Sell My Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2025 MJH Life Sciences

All rights reserved.